This is accurate, and gets into the somewhat more straightforward question of why branded drugs are expensive. Those seemingly ridiculous prices do indeed reflect a lot of very costly R&D, including for the host of medications that failed Phase II and III trials.

Generic medications, on the other hand, really should be expected to correlate somewhat with wholesale prices once there's competition. This does hold true for the (much healthier and more functional) over-the-counter drug market.